Carleton, B C <br/><br/>
Response to "evaluation of pharmacogenetic markers to predict the risk of Cisplatin-induced ototoxicity".  [electronic resource] 

 -  Clinical pharmacology and therapeutics  Aug 2014 
 - 158 p.  digital 
<br/><br/> Publication Type: Letter; Research Support, Non-U.S. Gov't; Comment 
<br/><br/><label>ISSN: </label>1532-6535 
<br/><br/><label>Standard No.: </label>10.1038/clpt.2014.90  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--toxicity<br/>Catechol O-Methyltransferase--genetics<br/>Cisplatin--toxicity<br/>Female<br/>Hearing Loss--chemically induced<br/>Humans<br/>Male<br/>Methyltransferases--genetics<br/>Multidrug Resistance-Associated Proteins--genetics